about
Verastem Inc is late-stage development biopharmaceutical company, committed to advancing new medicines for patients battling cancer. Its pipeline is focused on novel anticancer agents that inhibit critical signaling pathways in cancer that promote ca...
Read More
8.11
-0.15
(-1.82%)
3.1M
XNAS Volume
XNAS 08 Oct, 2026 5:30 PM (EDT)
Board Meeting
The next board meeting for Verastem Inc is on 14 Oct 2026 for the purpose of Verastem Oncology VS-7375 R&D Update
See details
Low Financial Strength
Expensive Valuation
Technically Moderately Bullish
Momentum Trap
These stocks have weak financials and expensive valuation. Buying interest may quickly dissipate. Investors should exercise caution
View Similar
Embed DVM
Verastem Inc Live Price Chart
Switch to TradingView
Loading Fundamental data..
Loading data..